{{Rsnum
|rsid=2243191
|Gene=IL19
|Chromosome=1
|position=206842612
|Orientation=plus
|GMAF=0.3526
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IL19
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 59.3 | 34.5 | 6.2
| HCB | 8.4 | 35.9 | 55.7
| JPT | 9.9 | 33.3 | 56.8
| YRI | 65.3 | 25.9 | 8.8
| ASW | 80.0 | 18.2 | 1.8
| CHB | 8.4 | 35.9 | 55.7
| CHD | 8.3 | 48.6 | 43.1
| GIH | 53.1 | 38.8 | 8.2
| LWK | 70.6 | 23.9 | 5.5
| MEX | 42.1 | 45.6 | 12.3
| MKK | 67.3 | 28.8 | 3.8
| TSI | 65.7 | 33.3 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20976276
|Title=Interleukin-10 (IL-10) Pathway: Genetic Variants and Outcomes of HIV-1 Infection in African American Adolescents
|OA=1
}}

{{PMID|16959027|OA=1
}} Novel IL10 gene family associations with systemic juvenile idiopathic arthritis.

{{PMID|18479293|OA=1
}} Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome.

{{PMID|21925224}} Protective role of interleukin-19 gene polymorphisms in patients with ulcerative colitis.

{{GET Evidence
|gene=IL19
|aa_change=Phe213Ser
|aa_change_short=F213S
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2243191
|overall_frequency_n=8558
|overall_frequency_d=10742
|overall_frequency=0.796686
|n_genomes=48
|n_genomes_annotated=0
|n_haplomes=75
|n_articles=0
|n_articles_annotated=0
|nblosum100=5
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}